This is unpublished
August 13, 2026
Local B cell response to recurrent varicella zoster virus infection
PI David Koelle and Co-I Christine Johnston have received a R21 award to support pregnant women who are at risk for transmitting the varicella zoster virus infection to their child.
Scroll for more
Dr. David Koelle, professor (Allergy and Infectious Diseases) has received an R21 award for his project, “Local B cell response to recurrent varicella zoster virus infection.”
The goal of the grant is to optimize human-derived monoclonal antibodies to replace the FDA-approved immunoglobulin product currently used for pregnant women who are at risk for transmitting varicella zoster virus infection to their child.
Co-PI is Dr. Christine Johnston.